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Abstract 
Study Objective: This systematic review aims to summarise the association 
between obstructive sleep apnea (OSA) and diabetic kidney disease (DKD).  
Design: MeSH terms and free text searches were performed on MEDLINE, 
EMBASE and Cochrane Database of Systematic Reviews from inception to April 
2015. Zetoc and OpenGrey databases were queried for grey literature and lastly, 
hand searches were carried out. Study selection and quality assessment were 
conducted by two authors. One author carried out data extraction, which was 
checked by other authors. The relationships between apnea-hypopnea index (AHI), 
oxygen desaturation index (ODI), time spent under 90% oxygen saturation 
(%TST<90), minimum and mean oxygen saturation (O2) on DKD were examined. 
Measurement and Results: Two longitudinal and ten cross-sectional studies were 
included for our narrative synthesis, and seven studies for meta-analysis. Studies 
that performed multi-variable analysis demonstrated significant associations between 
OSA (assessed using either apnea-hypopnea index or ODI) and DKD in type 2 
diabetes mellitus (T2DM).  This was confirmed by meta-analysis (pooled OR 1.73, 
95% CI: 1.13-2.64). There was some evidence to suggest that %TST<90 may have 
an association with DKD. There was insufficient evidence to conclude on the 
relationship between minimum and mean oxygen saturation on DKD. There was no 
evidence available on the associations between OSA and other respiratory 
parameters in type 1 diabetes mellitus populations.  
Conclusion: There is moderate evidence that OSA is associated with DKD in 
patients with T2DM. Large prospective studies with long-term follow up are needed 
to assess the possible bi-directional mechanisms between OSA and DKD. 
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Introduction 
Obstructive sleep apnea (OSA) is a chronic sleep disorder characterized by episodic 
complete or partial upper airway obstruction causing intermittent hypoxemia (IH) and 
sleep fragmentation. The prevalence of OSA amongst patients with diabetes mellitus 
(DM) is high1 and OSA has been shown to influence glycemic control2 and blood 
pressure3, two common factors contributing to vascular complications in DM. Apart 
from an impact on glycemic control4 and hypertension3, OSA and accompanying IH 
can trigger shared pathophysiological pathways mediating DM vascular 
complications including activation of oxidative and inflammatory pathways and 
greater production of advanced glycation end products (AGEs)5. Thus, identifying 
and addressing factors such as OSA may contribute to the prevention, delay, and 
amelioration of the serious DM vascular complications that significantly impinge on 
quality of life and increase mortality6. The evidence regarding the relationships 
between OSA and DM complications, however, is inconsistent and has not been 
systematically reviewed.  
In the context of diabetic kidney disease (DKD), a common and serious DM 
complication, one study found no significant correlation between urinary albumin 
creatinine ratio (ACR) and OSA7 while another study found that chronic IH was 
associated with a three-fold increase in odds for macro-albuminuria and a two-fold 
increase for micro-albuminuria8. Our previous work showed that the measure of 
OSA, the apnea-hypopnea index (AHI), defined as the average number of complete 
and partial airway obstruction events per hour of sleep during the night, had an 
inverse relationship with estimated glomerular filtration rate (eGFR) in DM patients 
with extreme obesity9. We also reported that the duration of nocturnal hypoxemia 
was related to a lower eGFR.  
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Due to the incongruity of the existing literature, the primary aim of this systematic 
review was to summarise the evidence on the association between OSA or chronic 
nocturnal hypoxemia with DKD. As nocturnal hypoxemia can be assessed differently 
according to different parameter definitions, we also examined the associations 
between oxygen desaturation index (ODI), minimum oxygen saturation, mean 
oxygen saturation and time spent below 90% oxygen saturation (%TST<90) on DKD 
to gain further insight into pathophysiological mechanisms. 
 
 
Methods 
 
The systematic review followed the recommendations by the Preferred Reporting 
Items for Systematic Review and Meta-analysis (PRISMA) statement10 as well as the 
Meta-analysis of Observational Studies in Epidemiology (MOOSE) statement11. The 
protocol was registered in Prospero database (registration number 
CRD42014008757). 
 
Eligibility criteria 
A summary of the eligibility criteria is presented in the supplementary materials. We 
had no language restrictions and the following inclusion criteria were used:  
 
Participants: Adults with either Type 1 diabetes mellitus (T1DM) or Type 2 diabetes 
mellitus (T2DM) were included.  
Exposure: T1DM and T2DM participants with a diagnosis of OSA.  It was not 
necessary for the diagnosis of OSA to follow the American Academy of Sleep 
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Medicine (AASM) guidelines12 using AHI obtained from polysomnography (PSG). 
Thus, studies using oxygen desaturation index (ODI) as a criterion for OSA were 
also included. However, we excluded studies which used screening questionnaires 
only as diagnostic criteria for OSA (such as the Berlin questionnaire or Epworth 
Sleepiness Score).  
Comparator: Participants without OSA were the comparator. 
Outcomes: The primary outcome was the risk of DKD assessed using either 
estimated glomerular filtration rate (eGFR) (<60ml/min/1.73m2) or albuminuria, which 
included both micro- and macro-albuminuria (>30mg/day) or urinary albumin 
creatinine ratio (>3.4mg/mmol).  
Study design: We included observational studies (cross-sectional, cohort or case-
control studies). We also included prevalence studiesthat include data on DKD.  
 
Search Strategy  
Index terms such as medical subject headings (MeSH) and free text were utilised to 
capture wide aspect of the literature. The search terms are described in 
supplementary materials. No restrictions were applied when searches were 
performed. The following electronic databases were searched from inception to 
January 2014: MEDLINE, Excerpta Medica DataBase (EMBASE) and Cochrane 
Database of Systematic Reviews. We also searched OpenGrey and Zetoc 
databases for grey literature such as conference abstracts. Free text “obstructive 
sleep apnoea” and “obstructive sleep apnea” were used for OpenGrey. For Zetoc, 
the following free text was used: “obstructive sleep apnoea/apnea and diabetes” and 
“apnoea/apnea and diabetes”. Citations of the included papers were also hand 
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searched for additional studies. An updated search on MEDLINE, EMBASE, 
OpenGrey and Zetoc was carried out from January 2014 to April 2015.  
 
 
Study Selection 
Titles and abstracts were independently reviewed by two authors to select eligible 
studies. Following that, full texts of the eligible studies were retrieved and studies 
were excluded if the inclusion criteria were not met. Again, two authors reviewed the 
full texts independently. Any disagreements were resolved through discussion and a 
third author was available to arbitrate when no consensus was reached. When 
duplicate or ‘kin’ studies were obtained, results from the most recent study or most 
comprehensive results were used for data synthesis and analysis.  
 
Data Extraction 
A pilot data extraction form was designed based on the Strengthening and Reporting 
of Observational studies in Epidemiology (STROBE) statement13. The form was 
piloted on a sample of 5 studies and further improvements made prior to formal use 
for the systematic review. One author performed data extraction, checked by other 
authors. For any missing data or when additional information was required, study 
authors were contacted. 
 
Assessment of study quality 
We designed a revised quality assessment form based on the Newcastle Ottawa 
Scale14 for non-randomised studies in the meta-analysis. Study quality was 
assessed on five components: selection bias, study methods, blinding of the 
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assessor carrying out sleep recording analysis, respiratory measurement and finally 
the overall analysis (supplementary materials). Each component consisted of a set of 
criteria and each criterion was rated as ‘yes’, ‘no’ or ‘unclear’. Following that, a 
judgment of either ‘weak’, ‘moderate’ or ‘strong’ were given to each component. 
Finally, an overall judgment of ‘weak’, ‘moderate’ or ‘strong’ was made. We utilised a 
rating system as per the Cochrane Collaboration recommendation15. Two authors 
carried out quality assessments independently. The form was piloted on studies and 
improvements were made prior to formal use.  
 
Data synthesis and analysis 
Narrative description was used to summarise our findings. Statistical analysis was 
carried out using Stata 13 (StatCorp LP, College Station, Texas). We performed a 
meta-analysis on the studies that reported unadjusted OR on the association 
between OSA (defined using AHI) and DKD. We also meta-analysed studies that 
only reported adjusted OR and 95% CI (relationships between ODI and AHI on DKD) 
because these results minimises the influence of potential confounders. All meta-
analyses were performed using random effects model analysis. 
Meta-analysis was not performed on the association between mean and minimum 
oxygen saturation or the percentage of time spent below 90% oxygen saturation 
(%TST<90) and DKD. Publication bias was assessed visually using funnel plot for 
meta-analyses which contained >5 studies. We also carried out kappa (к) statistics to 
assess the agreement between the two authors for study selection (87%, к statistic = 
0.71, p<0.001) and quality assessment (89%, к statistic = 0.80, p<0.0004). 
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Results 
The initial searches identified a total of 1163 studies (1129 from databases and 34 
from grey literature). An updated search in April 2015 identified 447 studies (350 
from databases and 97 from grey literature). After excluding duplicates, there were 
1509 studies and 1474 were subsequently removed after title and abstract 
screening. Thirty-five full text articles were retrieved. We excluded 23 articles: 10 
studies did not include DM populations, 9 were duplicate studies, 2 did not include 
participants with OSA, 1 study did not have DKD as an outcome and 1 study was a 
review article. A total of 12 studies were included in our narrative synthesis. Figure 1 
showed the PRISMA flow chart for study selection.  
 
Study characteristics 
The majority of the studies had a cross-sectional study design except two16, 17 which 
included a follow-up component. Most studies (n=7) were from Europe7, 9, 16-20, two 
studies were from Japan8, 21, two from China22, 23 and one from the USA24. There 
were a total of 4344 DM participants (4286 T2DM) across all studies. The mean age 
of participants ranged from 51 to 62 years and the proportion of females ranged from 
32% to 73%7-9, 16-24. The mean HbA1c and DM duration were between 6.5 and 9.2% 
and 7.5 and 15.0 years7-9, 16-24 respectively. One study9 only included extremely 
obese individuals with a mean BMI of 46.8Kg/m2. For the remainder of the studies7, 8, 
16-24, mean BMI ranged from 25.2 to 37.0Kg/m2.  
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 The characteristics of the studies are summarized in Table 1. Most of the studies 
used an ambulatory sleep device with 3 channels (oximetry, air-flow, and respiratory 
effort) to assess OSA9, 16, 22, 24 while one performed full polysomnography (PSG)7. 
Others used a two-channeled device18, 19, mixed methods20 or pulse oximetry for 
sleep assessment8, 21. One study used a single-channel recording device, 
unfortunately, the authors did not specify which channel23. One study did not report 
on the device used for overnight respiratory assessment17.  
 
A small degree of heterogeneity was present for the definition of apneas and 
hypopneas as well as OSA diagnosis (please see supplementary materials for 
details). As expected, there were variations in the diagnoses of DKD. Six studies 
reported on albuminuria results7, 8, 18, 20, 22, 24. One UK study reported on both urinary 
ACR and eGFR16. The eGFR was calculated using the Modification of Diet in Renal 
Disease (MDRD) equation. Another UK study9 only used eGFR, calculated using the 
MDRD and the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 
formulae. Additionally, a Japanese study21 utilized serum creatinine levels (mg/dl).  
 
Narrative review of OSA (defined by AHI) and DKD 
Ten studies (n=2927) out of a total 12 studies examined the association between 
OSA (using apnea-hypopnea index) and DKD7, 9, 16-20, 22-24. Seven studies (n=1729) 
performed unadjusted analysis,7, 18-20, 22, 24; only one study demonstrated significant 
association18. Univariate and multivariate analyses were carried out by two UK-
based studies and one Chinese study (n=1198)9, 16, 23. The Chinese study 
demonstrated significant associations after adjusting for age and gender23. Leong et 
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al. demonstrated a linear association between AHI and MDRD eGFR9. However, this 
was not confirmed using the CKD-EPI formula. Table 1 list the covariates used for 
adjustment. The longitudinal study by Tahrani and colleagues reported that OSA was 
an independent predictor for DKD after adjusting for a range of confounders at 
baseline16. Additionally, 196 participants were followed-up for 2.5±0.7 years and 
OSA was associated with a lower study-end MDRD eGFR result (p=0.04) after 
adjusting for confounders. Substituting OSA with AHI revealed similar results 
(p=0.02).  
 
Meta-analysis of OSA (defined by AHI) and DKD 
A meta-analysis was carried out for seven studies which reported unadjusted ORs 
on the relation between OSA and DKD7, 9, 16, 18-20, 22. The pooled estimates showed a 
small, but significant association, with higher risk of DKD in those who have OSA 
(pooled OR 1.59, 95%CI: 1.16-2.18, I2=26.8%; see supplementary materials). The 
funnel plot of these studies7, 9, 16, 18-20, 22 suggest an imbalance of small studies with 
positive results (see supplementary materials). In summary, pooling of studies using 
crude ORs suggests that there is a significant association between OSA and DKD. 
Our narrative review on studies9, 16, 23 that undertake multivariate analysis also 
support this hypothesis. Additionally, the one study16 which followed up patients 
longitudinally, showed that patients with DM who have OSA had a higher risk of 
DKD.  
 
Narrative review of DKD and oxygen desaturation index 
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Two studies (n=1317) from Japan used drop in oxygen levels during sleep (3%ODI 
≥5events/hr) as the diagnostic criterion for OSA8, 21. Both reported a significant 
association between ODI and DKD.  
 
 
 
 
 
Meta-analysis of DKD and oxygen desaturation 
A meta-analysis was carried out on these two studies8, 21 resulting in a pooled OR 
2.00, 95%CI:1.36 to 2.94 (I2=0.0%; supplementary materials). Combining the studies 
by Tahrani16 and Zhang 201423 which used AHI criterion for OSA diagnosis into the 
model showed similar results (pooled OR 1.73, 95% CI: 1.13 to 2.64 I2=69.3%) as 
shown in Figure 2. However, substantial heterogeneity25 is present therefore the 
pooled results should be interpreted with caution. Publication bias cannot be ruled 
out. In summary, our narrative synthesis outlined a likely association between sleep 
apnoea as measured by ODI on DKD in patients with T2DM, and this was confirmed 
by our meta-analysis. 
 
Narrative review of DKD and other respiratory parameters 
Three studies (n=491) examined the relation between minimum oxygen saturation 
and DKD9, 16, 24, with only one reporting a significant association24. Two studies 
examined the association between mean oxygen saturation (n=158) and DKD9, 17, in 
which only one study showed a significant association17. The association between 
the percentage of time spent under 90% oxygen saturation (%TST<90) and DKD 
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was also assessed by two studies (n=158) and both reported significant 
associations9, 17.  
 
In summary, there was insufficient evidence to conclude on the relationship between 
the level of hypoxemia and mean oxygen saturation and DKD. Our narrative review 
suggests that %TST<90 may have an association with the risk of DKD.  
 
 
 
Quality assessment 
The quality of the studies is summarised in Table 2. Overall, the studies were of 
poor-to-moderate quality (n=10)7, 8, 17-24. Only 2 studies were rated as high quality9, 16. 
The majority of studies were at risk of selection bias (n=8)7, 8, 17, 19, 20, 22-24. In addition, 
only one study reported respiratory scoring with an assessor blinded of the 
participants’ clinical characteristics9. Several studies were rated at least moderate for 
methods of sleep assessment (n=9)7-9, 16, 18-22. The majority of studies scored 
reasonably well for study methods (n=6)9, 16, 18-20, 24 with several studies only carrying 
out univariate analyses (n=7)7, 17-20, 22, 24.  
 
Discussion  
Our narrative synthesis demonstrated moderate evidence for a possible association 
between OSA (diagnosed using AHI) and DKD. This was confirmed by a meta-
analysis on the studies that carried out univariate analysis. Nevertheless, crude ORs 
are subjected to multiple confounders such as age, gender and BMI which may lead 
to an overestimation of the results. Studies which performed multivariate analysis 
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adjusted for important confounders such as BMI, gender and DM duration, also 
demonstrated a significant association between OSA and DKD9, 16, 23. Additionally, 
the only longitudinal study with medium-term follow up also showed a significant 
decline of eGFR in individuals with T2DM and OSA16. In that study, 47 participants 
were offered continuous positive airway pressure (CPAP) treatment with 16 being 
CPAP adherent. The eGFR decline was slower in the CPAP-adherent group (-7.7%, 
95%CI:-15.9% to -1.8% compared to non-compliant group (-10.0%, 95%CI:-17.2%-
2.3%). Although the CPAP results were not adjusted for important confounders and 
has no control group for comparison, it suggests that reversing sleep apnea using 
CPAP may contribute to decelerating the decline in renal function.  
 
One of the excluded studies, the Nutritional Health And Nutrition Examination Survey 
(NHANES) study, was published as a conference abstract26. The study was 
excluded because only 9.5% of the participants were diabetic and it was unclear 
whether the self-reported sleep apnea was central or OSA. Multivariate regression 
analysis demonstrated that when DM and sleep apnea coexist, the risk of micro-
albuminuria was three-fold higher (OR 3.4, 95%CI:1.80-6.39) and risk of macro-
albuminuria was 11-times greater (OR 11.39, 95%CI:4.60-28.42) after adjusting for 
confounders. Assuming the diagnosis of sleep apnea was obstructive in nature in the 
majority of the participants, this strengthens the evidence of the association between 
OSA and DKD in T2DM. Our narrative review also suggests that %TST<90 may 
have an association with DKD. Currently, there is a dearth of information on the 
relationship between OSA, as well as the other respiratory parameters, and DKD in 
T1DM population. 
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A small degree of heterogeneity was identified in the methods and the criteria used 
for OSA diagnosis. The majority of studies utilised either level III or level IV portable 
devices because they are less costly and less labor intensive. A recent meta-
analysis that compared portable devices to the gold standard in-hospital full PSG 
reported a good diagnostic performance with areas under curve of between 0.85 and 
0.99 according to OSA severity27. Differences also occurred with DKD diagnosis. 
Some studies used albuminuria whilst others used either eGFR or creatinine levels. 
Nonetheless, several studies demonstrated a significant association with 
assessment of either albuminuria or eGFR8, 9, 21 suggesting that the relationship 
between OSA and DKD might be much larger and the effect size likely to be 
underestimated. Almost all the studies were cross-sectional in design therefore 
unable to demonstrate causality. However, the cohort study16 reported significant 
deterioration of eGFR after 2.5 years of follow-up. Measures of nocturnal hypoxemia, 
however, were not associated with eGFR decline in the final analysis.  
 
OSA is likely to impact on both the development and progression of DKD through 
several mechanisms. IH caused by OSA has been documented to cause greater 
levels of oxidative stress, and activation of inflammatory pathways, leading to 
endothelial dysfunction28, 29. Additionally, the intermittent intra-renal hemodynamic 
changes from recurrent sympathetic overdrive secondary to sleep fragmentations 
can cause ischemia with intra-renal reperfusion injury leading to intrinsic renal 
injury30. Case reports on participants with OSA have shown secondary focal 
glomerulosclerosis31, 32 and in one case, complete resolution of proteinuria after bi-
level positive airway pressure treatment32.  
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In addition, studies have shown a dose-response relationship between the severity 
of OSA and glycaemia2. This is likely to involve several mechanisms including 
excess sympathetic activity, activation of the hypothalamic-pituitary-adrenal axis, 
direct insult to beta-cell function, and activation of deleterious inflammatory 
molecular pathways adversely affecting insulin sensitivity6. Collectively, these 
mechanisms result in greater insulin resistance among DM participants and greater 
insulin resistance amongst those with T2DM that has been shown to be a predictor 
of the development of micro-albuminuria irrespective of other metabolic profiles33. 
Furthermore, OSA is a known cause of resistant hypertension34, and hypertension is 
a major risk factor for renal damage35.  
 
It is also plausible that diabetic microvascular complications cause or exacerbate 
OSA. It is well known that diabetes-related microvascular complications often co-
exist. Consequently, those with DKD might also have diabetic neuropathy. Diabetic 
autonomic neuropathy can affect muscular control of the pharynx increasing the risk 
of airway collapsibility. In a case series, OSA was found to correlate highly with 
hereditary motor and sensory neuropathy disease (Charcot-Marie-Tooth disease)36. 
Likewise, patients with diabetic autonomic neuropathy have been reported to have a 
greater risk of OSA compared with those without37, 38. Therefore, there is likely to be 
a two-way association between OSA and DKD39. 
 
This systematic review has several limitations. The majority of the studies were 
cross-sectional which may be subject to selection bias40. Most of the studies did not 
blind the DKD outcome from the assessor who scored the sleep recording reflecting 
possible measurement bias. A few studies were in the form of conference abstracts 
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with very limited detail and our quality assessment might not have comprehensively 
assessed the rigour of these studies. The issue of residual confounders remained as 
several studies carried out unadjusted analyses. This may represent an 
overestimation of the effect sizes. Although the majority of the studies were from the 
European counties with two studies from Japan, two from China and one from the 
US, the underlying mechanistic effects between OSA and DKD should not differ in 
other populations therefore our results should be generalisable to all T2DM 
populations. 
 
Conclusion  
Our systematic review demonstrated that OSA, defined as using AHI or ODI, was 
associated with DKD in T2DM. There is a dearth of information on the relationship 
between OSA and DKD amongst T1DM. In light of the plausible bi-directional 
mechanisms between OSA and DKD, there is a need for large prospective studies 
with long-term follow-up to determine the impact of OSA parameters on both 
albuminuria and eGFR in both T1DM and T2DM populations.   
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Table 1: Characteristics of included studies 
Study ID 
(country) 
Study 
design 
Participants Demographics Diabetes 
parameters 
OSA 
assessment 
and diagnosis 
Results  
Buyukaydin 
2012 
(Turkey)7 
CS 52 T2DM 
 
Setting = Diabetes 
clinic 
Mean age = 56 years 
Females = 73% 
Mean BMI = 32.4 
Kg/m2 
Mean HbA1c 
= 7.9% 
 
Mean DM 
Duration = 
12.8 years 
 
Inpatient PSG 
(Compumedics E 
3142)  
OSA = AHI ≥5 
events/hr 
Univariate analysis 
- No difference in albuminuria between 
OSA (21.9%) and non-OSA (29.4%) 
groups. 
- No difference in AHI between micro-
albuminuria 9.0±14.6 vs. no micro-
albuminuria 10.5±10.0events/hr (p>0.05) 
 
Furukawa 
2013 
(Japan)8 
CS 513 T2DM Setting = Multi-center 
diabetes clinics 
Mean age = 62 years 
Females = 43% 
Mean BMI = 25.2 
Kg/m2 
Mean HbA1c 
= 7.3% 
 
Mean DM 
Duration = 
11.7 years 
 
 
Oximetry 
(PULSOX-3Si) # 
3% ODI ≥5 
events/hr 
Multivariate analysis 
- Association between ODI and micro-
albuminuria (OR 1.84, 95% CI: 1.16 to 
2.96) 
- Association between ODI and macro-
albuminuria (OR 2.97, 95% CI: 1.36 to 
6.90) 
Adjusted for age, sex, BMI, hypertension, 
hyperlipidemia, smoking, alcohol, 
medications for stroke and IHD, duration 
of DM and HbA1c. 
 
Kosseifi 
2010ǁ (US)24 
CS 98 T2DM Setting = Sleep clinic 
Mean age = 61 years 
Females = NA$ 
Mean BMI = 33.7 
Kg/m2 
Mean HbA1c 
= 6.5% 
 
Mean DM 
Duration = 
NA 
 
Level III sleep 
test (NovaSom 
QSG) 
OSA = NA 
Univariate analysis  
- No difference in AHI between micro-
albuminuria 33.5 vs. no micro-
albuminuria 28.0events/hr (p>0.05) 
- Significant difference in oxygen 
saturation in micro-albuminuria 73.0% 
vs. no micro-albuminuria 77.4% 
(p<0.01) 
 
Laaban 
2009ǁ 
CS 303 T2DM Setting = Hospital 
inpatient (DM) 
Mean HbA1c 
= 9.2% 
Level IV sleep 
test (CID 102) ǂ~ 
Univariate analysis  
- No difference in albuminuria between 
21 
 
(France)18 Mean age = 61 years 
Females = 49% 
Mean BMI = 32.0 
Kg/m2 
 
Mean DM 
Duration = 
14.5 years 
 
OSA = AHI ≥5 
events/hr 
groups: non-OSA (25%), mild OSA 
(34%), moderate OSA (38%) or severe 
OSA (39%). 
- Association between OSA and 
albuminuria (unadjusted OR 1.90, 95% 
CI: 1.10 to 3.31). 
 
Langrand C 
2014 a 
(France)17 
Cohort 68 T2DM Setting: NA 
Mean age = 62 years 
Females = 43% 
Mean BMI = 37 Kg/m2 
 
Mean HbA1c 
= 8.1% 
 
Mean DM 
Duration = 
15.0 years 
Sleep test = NA 
OSA = NA 
Univariate analysis 
- Significant association between 
diabetic kidney disease and mean 
nocturnal oxygen saturation (OR 
0.814, 95% CI: 0.671 to 0.9880) 
- Significant association between 
%TST<90 and diabetic kidney disease 
(OR 1.026, 95% CI: 1.001 to 1.051) 
- No association between AHI and 
diabetic kidney disease 
 
Leong 2014 
(UK)9 
CS 90 T2DM Setting = Specialist 
weight management 
clinic 
Mean age = 51 years 
Females = 57% 
Mean BMI = 46.8 
Kg/m2 
Mean HbA1c 
= 8.3% 
 
Mean DM 
Duration = 
7.5 years 
 
Level III sleep 
test (Embletta) 
#~ 
OSA = AHI ≥5 
events/hr 
Multivariate analysis (linear regression) 
- Association between AHI and MDRD 
eGFR (β=-0.17, 95% CI: -0.32 to 0.02). 
- Association between %TST<90 and 
MDRD eGFR (β=-0.22 to 95% CI: -0.41 
to 0.02). 
- No association between mean O2 and 
MDRD eGFR (β=1.91, 95% CI: -0.04 to 
2.42). 
- No association between minimum O2 
and MDRD eGFR (β=0.05, 95% CI: -0.39 
to 0.50) 
 
- No association between AHI and CKD-
EPI eGFR (β=-0.19, 95% CI: -0.39 to 
0.01) 
Adjusted for age, gender, BMI, 
22 
 
hypertension, IHD, DM duration, insulin 
treatment, RAS treatment. 
 
- Association between %TST<90 and 
CKD-EPI eGFR (β=-0.30, 95% CI: -0.56 
to 0.03) 
- No association between minimum O2 
and CKD-EPI (β=0.16, 95% CI: -0.44 to 
0.76) 
- No association between mean O2 and 
CKD-EPI (β=1.50, 95% CI: -0.21 to 3.22) 
Adjusted for age, gender, BMI, 
hypertension, IHD, DM duration, insulin 
treatment, RAS treatment. 
 
Schober 
2011ǁ 
(Germany)19 
CS 58 T1DM & 
498 T2DM 
Setting = 14 primary 
care centers 
Mean age = 60 years 
Females = 48% 
Mean BMI = 31.9 
Kg/m2 
Mean HbA1c 
= 7.6% 
 
Mean DM 
Duration = 
9.3 years 
 
Level IV sleep 
test (ApneaLink) 
ǂ~ 
OSA = AHI ≥15 
events/hr 
Univariate analysis 
- Significant difference between 
groups: AHI<5/hr 13 patients, AHI 5-
14/hr 46 patients, AHI≥15/hr 42 
patients (p=0.001). 
- No association between OSA (AHI 
≥15/hr) and nephropathy (unadjusted OR 
1.24, 95% CI: 0.80 to 1.92). 
 
Storgaard 
2014ǁ 
(Denmark)20 
CS 180 T2DM Setting = Diabetes 
clinic 
Mean age = 59 years* 
Females = 42% 
Mean BMI = 32.2 
Kg/m2* 
Mean HbA1c 
= 7.4%* 
 
Mean DM 
Duration = 
8.2 years* 
 
Berlin Q and 
ApneaLink +/- 
level III sleep 
test (Embletta) # 
OSA = AHI ≥5 
events/hr 
Univariate analysis 
- No association between OSA and 
albuminuria (OR 1.38, 95% CI: 0.76 to 
2.53). 
Tahrani 
2013 (UK)16 
Cohort 224 T2DM Setting = 2 diabetes 
clinics 
Mean age = 57 years* 
Females = 42% 
Mean HbA1c 
= 8.2%* 
 
Mean DM 
Level III sleep 
test (Alice PDX) 
#~ 
OSA = AHI ≥5 
Multivariate analysis  
- Association between OSA and 
nephropathy (OR 2.64, 95% CI: 1.13 to 
6.16) 
23 
 
Mean BMI = 33.5 
Kg/m2* 
Duration = 
10.0 years* 
 
events/hr - No association between minimum O2 
and nephropathy (OR 0.96, 95% CI: 0.93 
to 1.00). 
Adjusted for age, sex, ethnicity, DM 
duration, BMI, mean arterial pressure, 
HbA1c, triglycerides, insulin, GLP-1, anti-
hypertensives, total cholesterol, high-
density-lipoprotein cholesterol, lipid-
lowering treatment, anti-platelets, oral DM 
agents, alcohol and smoking 
 
- After 2.5 years follow-up: linear 
regression showed OSA predicted 
study end MDRD eGFR (β=-3.8, p=0.04) 
and AHI associated with study end 
MDRD eGFR (β=-4.6, p=0.02).  
Adjusted for age, DM duration, ethnicity, 
sex, BMI, mean arterial pressure, anti-
hypertensive agents, HbA1c, insulin, oral 
DM agents, total cholesterol, lipid 
lowering treatments, antiplatelet agents 
and smoking. 
- No association between minimum O2 
and study end eGFR (effect size not 
reported) 
 
Tanaka 
2009a ǁ 
(Japan)21 
CS 904 T2DM Setting = Multicenter 
diabetes clinics 
Mean age = 62 years* 
Females = 33% 
Mean BMI = 25.3 
Kg/m2 
Mean HbA1c 
= 6.9% 
 
Mean DM 
Duration = 
10.3 years* 
 
Oximetry  
3% ODI ≥ 5 
events/hr 
Multivariate analysis 
- Association between OSA and 
creatinine (OR 2.37, 95% CI: 1.21 to 
4.65) 
Adjusted for age, gender, BMI, heart rate 
and hypertension. 
Zhang R 
2014a ǁ 
CS  884 T2DM Setting = Multicenter  
Mean age = NA 
Mean HbA1c 
= NA 
Single channel 
recording device 
Multivariate analysis 
- Association between OSA severity 
24 
 
(China)23 Females = NA 
Mean BMI = NA 
 
 
Mean DM 
Duration = 
NA 
 
OSA = AHI >5 
events/hr 
and stages of diabetic kidney disease 
(OR 1.18, 95% CI: 1.03 to 1.34)  
- Linear association between AHI and 
serum creatinine (b=3.49, p=0.024) 
- Linear association between AHI and 
microalbuminuria (b=3.49, p=0.024) 
Adjusted for age and gender 
 
Zhang R 
2015ǁ 
(China)22 
CS 472 T2DM Setting = Multicenter 
inpatient 
Mean age = 55 years 
Females = 32% 
Mean BMI = 26.5 
Kg/m2 
Mean HbA1c 
= 9.1% 
Mean DM 
Duration =  
7.0 years 
Level III sleep 
test 
(ApneaLink)~ 
OSA = AHI ≥ 5 
events/hr 
Univariate analysis 
- No association between albuminuria 
and OSA (OR 1.56, 95% CI: 0.80 to 3.03) 
NA=information not available, HbA1c=glycosylated haemoglobin A1c, DM=Diabetes mellitus, BMI=body mass index, CS = cross-sectional study, 
T1DM=Type 1 diabetes mellitus, T2DM=Type 2 diabetes mellitus, OSA=obstructive sleep apnea, PSG=polysomnography, ODI=oxygen 
desaturation index, AHI=apnea-hypopnea index, O2=oxygen saturation, eGFR=estimated glomerular filtration rate, MDRD=modification of Diet 
in Renal Disease, CKD-EPI=chronic kidney disease Epidemiology Collaboration, IHD=ischemic heart disease, RAS=renin-angiotensin system, 
GLP-1=glucagon-like peptide-1. 
ǂPSG data did not have data on effort; #Minimum 4 hours recording; $Veteran study with low female participants; *Average values from 2 
groups; 
a Conference abstracts; ǁ Prevalence studies; ~Portable home sleep study. Bolded texts represent significant results. 
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Table 2: Quality assessment of included studies 
  Components  
Study  Selection bias Methods and 
measurement 
Blinding Study design Analysis  Overall 
Buyukaydin 20127 Weak  Strong Weak Weak Weak Weak 
Furukawa 20138 Weak Moderate  Weak Weak Strong Weak 
Kosseifi  201024 Weak Weak Weak Moderate Weak Weak 
Laaban 200918 Moderate Strong Weak Moderate Weak Moderate 
Langand 201417 Weak Weak Weak Weak Weak Weak 
Leong 20149 Strong Strong Strong Moderate Strong Strong 
Schober 201119 Weak Moderate Weak Strong Weak Weak 
Storgaard 201420 Weak Moderate Weak Strong Weak Weak 
Tahrani 201316 Weak Strong Weak Strong Strong Strong 
Tanaka 200921 Moderate Moderate Weak Weak Strong Moderate 
Zhang 201423 Weak Weak Weak Weak Moderate Weak 
Zhang 201522 Weak Moderate Weak Weak Weak Weak 
26 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: PRISMA flow chart on study selection  
OSA = obstructive sleep apnea; DKD = diabetes kidney disease; DM = diabetes 
mellitus 
*Meta-analysis carried out in 7 studies which reported on unadjusted odds ratios 
$Meta-analysis carried on 4 studies which reported on adjusted odds ratios 
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Full-text articles assessed 
for eligibility  
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Full-text articles excluded  
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No OSA   (n=2) 
No DKD   (n=1) 
Not DM   (n=10) 
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Studies included in 
qualitative synthesis 
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Studies included in quantitative 
synthesis (meta-analysis) 
 
OSA (AHI) on DKD* (n=7) 
ODI and AHI on DKD$  (n=4) 
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Figure 2: Forest plot of the association between obstructive sleep apnea (OSA) and 
diabetic kidney disease using results from studies which reported adjusted odd ratios 
and 95% confidence intervals. Note: Furukawa 20138 and Tanaka 200921 diagnosed 
OSA using 3% ODI ≥5events/hr whilst Tahrani 201316 and Zhang 201423 diagnosed 
OSA based on AHI ≥5events/hr.  
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Overall  (I-squared = 69.3%, p = 0.021)
Tanaka 2009
Study
Zhang 2014
Tahrani 2013
ID
Furukawa 2013
1.73 (1.13, 2.64)
2.37 (1.21, 4.65)
1.18 (1.03, 1.34)
2.64 (1.13, 6.16)
OR (95% CI)
1.84 (1.16, 2.96)
100.00
19.83
%
38.14
15.33
Weight
26.70
  1.162 6.16
28 
 
